West Pharmaceutical Services (NYSE: WST) recently received a number of ratings updates from brokerages and research firms: 7/15/2026 – West Pharmaceutical Services had its “buy” rating reaffirmed by TD Cowen. 7/13/2026 – West Pharmaceutical Services is now covered by BNP Paribas Exane. They set an “outperform” rating and a $447.00 price target on the stock. […]

Several analysts have recently updated their ratings and price targets for Methode Electronics (NYSE: MEI): 7/4/2026 – Methode Electronics was upgraded by Wall Street Zen from “hold” to “buy”. 6/30/2026 – Methode Electronics was downgraded by Zacks Research from “hold” to “strong sell”. 6/29/2026 – Methode Electronics was upgraded by Barrington Research from “market perform” […]